去甲斑蝥素对HO-8910PM细胞中NAG-1表达的影响  被引量:2

Effect of norcantharidin on the expression of NAG-1 in HO-8910PM cell line

在线阅读下载全文

作  者:何太平[1] 莫丽儿[2] 梁念慈[1] 

机构地区:[1]广东医学院生物化学与分子生物学研究所,湛江524023 [2]广东天然药物研究与开发重点实验室,湛江524023

出  处:《中国药科大学学报》2007年第4期356-359,共4页Journal of China Pharmaceutical University

基  金:广东省医学科研基金资助项目(No.B2005104);广东省中医药局课题资助项目(No.1060044)~~

摘  要:目的:研究去甲斑蝥素对人高转移卵巢癌HO-8910PM细胞中非类固醇抗炎药物激活基因(non-steroidal anti-in-flammatory drug-activated gene,NAG-1)表达的影响,探讨其抗肿瘤的作用机理。方法:应用肿瘤基因芯片、荧光定量实时PCR和Western blot法检测去甲斑蝥素对NAG-1表达的影响。结果:去甲斑蝥素能明显上调NAG-1表达,3种方法检测去甲斑蝥素上调HO-8910PM细胞中NAG-1表达的倍数分别为6.69、8.33±0.76和16.00倍。结论:去甲斑蝥素抗肿瘤作用与NAG-1表达有关。Aim:To investigate effect and its mechanism of norcantharidin on the expression of nonsteroidal anti-infla mmatory drug-activated gene(NAG-1) in the highly metastatic ovarian carcinoma HO-8910PM cells. Methods: The expression level of NAG-1 was assessed by using the mieroarray chip. Quantitative real-time fluorescent PCR assay and Western blot were used to verify the effect of norcantharidin on NAG-1 expression. Results: Microarray chip, fluores- cent quantitative real-time PCR and Western blot results showed that norantharidin significantly up-regulated the expression of NAG- 1, the relative mRNA and protein level of NAG- 1 were 6.69, 8.33± 0.76, 14.00 fold of control group, respectively. Conclusion: Anti-tumor activity and its mechanism of norcantharidin in HO-8910PM cells are associated with the expression of NAG-1.

关 键 词:去甲斑蝥素 卵巢癌 非类固醇抗炎药物激活基因 表达 

分 类 号:R737.31[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象